Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05500755

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA).

Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met.

Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Dental Implants

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Clínica Dental esteve

Alicante, 03001, Spain

Location status: Recruiting

Location contact

Guillem Esteve-Pardo, PhD

CONTACT

[email protected]

+34 965215755

Guillem Esteve-Pardo, PhD

PRINCIPAL_INVESTIGATOR

About this study

The DS PrimeTaper implant has macro-design features that differ from its predecessor, the OsseoSpeed EV implant (AstraTech Implant System EV, Dentsply Implants, Mölndal, Sweden) with which they share a common surface and internal connection.

Its macro-design has been modified through the introduction of variable thread forms and a more pronounced taper, ultimately making it more aggressive in terms of cutting ability.

While its predecessor, the OsseoSpeed EV implant, has sufficient scientific support, this new system recently introduced on the market does not. All the scientific contributions that can be made will therefore be a first guide for the clinician who wishes to start using this dental implant system.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All the patients whom received at least one DS Prime Taper implant.

Exclusion criteria

  • When dental implant surgery is contraindicated.

Treatment and study plan

Implant Treatment

Device

Surgical placement of a DS Prime Taper implant and its posterior prosthesis.

Other names: Implant surgery, Implant prosthesis, Implant placement

Primary outcomes

  1. Implant Survival Rate

    Time frame: through study completion, an average of 1 year

    Time of survival of DS Prime Taper dental implant placed

  2. Implant Success Rate

    Time frame: through study completion, an average of 1 year

    Radiological assessment of Marginal Bone Levels around DS Prime Taper implants in function

  3. Biological and mechanical complications events

    Time frame: through study completion, an average of 1 year

    All type of complications that may occur during implant survival

Study contacts

Contact information is provided by the study sponsor or research team.

Guillem Esteve-Pardo, PhD

CONTACT

[email protected]

+34965215755

Sponsors and collaborators

Lead sponsor

Aula Dental Avanzada

Other

Registry information

Official study title

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants: A Prospective Medium Term Study

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Aug 15, 2022
Registry last updated
Aug 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.